Healthcare & Medical Devices
Global X-Ray Photoelectron Spectroscopy market trends: Healthcare sector to display heavy growth potential
Mounting need for analyzing surface chemistry of materials will drive X-Ray Photoelectron Spectroscopy (XPS) market size over the coming years. Escalating demand for XPS across pharmaceuticals, medical research, mining, chemical, and food sectors is expected to boost the industry trends. According to Global Market Insights, Inc., “Worldwide X-ray photoelectron spectroscopy market worth 475 million in 2015, is predicted to record a CAGR of 6% over the period of 2016 to 2023.” Growing requirement for detecting defects such as dewetting, craters, etc., along with the need to identify the problems during automotive coatings will further propel the industry growth. Furthermore, favorable compensation policies, the presence of laboratories equipped with new technologies, and rising health awareness are other pivotal growth drivers of the industry.
U.S. X-ray Photoelectron Spectroscopy Market Size, By Application, 2012-2023 (USD Million)
X-ray photoelectron spectroscopy has noteworthy usages such as empirical formula determination, element detection, density estimation and contamination detection. X-ray photoelectron spectroscopy market in the contamination detection will exhibit fastest growth rate of more than 6% over the coming years of 2016 to 2023. The growth can be attributed to its surging demand across pharmaceutical, semiconductor, biotechnology, and electronics industries. Density estimation, element detection, and empirical formula determination will also contribute substantially towards the industry growth.
Get a Sample Copy of this Report:@ https://www.gminsights.com/request-sample/detail/431
Among the various notable applications such as bioengineering, automotive, electronics, semiconductor, aerospace, and healthcare of the X-ray photoelectron spectroscopy industry, healthcare application exhibited the eye-catching revenue and accounted for 40% of the global share in 2015. The escalating technological advancements and growing healthcare spending will further drive X-ray photoelectron spectroscopy industry size in the bioengineering sector.
X-ray photoelectron spectroscopy market size in the automotive sector will register an annual growth rate of 6.7% over the coming six years, primarily driven by its increasing use for finding defects and detecting contaminants.
Geographically, Asia Pacific X-ray photoelectron spectroscopy market share is anticipated to grow noticeably over the coming timeframe, owing to the developing infrastructure sector as well as expanding healthcare industry. China and India will be major revenue drivers for the APAC. India X-ray photoelectron spectroscopy industry will exhibit a growth rate of more than 8% over the coming years.
Supportive government rules & regulations as well as availability of fully developed laboratories will fuel the UK X-ray photoelectron spectroscopy industry size over the period of 2016 to 2023.
U.S. X-ray photoelectron spectroscopy industry share is projected to surpass revenue of USD 250 million by 2023. The surging installation of the instruments, which are incorporated with new innovative and enhanced technology are expected to fuel the regional demand growth. In addition, favorable government norms along with the implementation of FDA approved health policies regarding drug safety and quality will influence the X-ray photoelectron spectroscopy market noticeably.
Market giants are adopting various growth strategies like collaborations, mergers & acquisitions to maintain their business position across the globe. Intertek, Kett, Evans Analytical Group LLC, VG Scienta, Kratos Analytical Ltd, Yokogawa, Mitsubishi Electric, and Thermo Fisher Scientific are some of the noteworthy players in the X-ray photoelectron spectroscopy market.
Author Name : Sunil Hebbalkar
Cell line development market is gaining massive business space in the industry due to the growing demand for biosimilars, novel drugs, and vaccines in the biotechnology industry. “Cell culture can be defined as the process by which cells are grown under controlled conditions, generally outside of their natural environment.” The development in research activities due to rising prevalence of cancer and auto immune disorders will create more need for cell lines, in turn fueling the global cell line development industry. According to Global Market Insights, Inc., “Cell Line Development Market size is anticipated to grow at a CAGR of 13% over the period of 2016-2023.” In addition to this, favorable government initiatives to improve healthcare set-up and the development of advanced technologies will subsequently surge the cell line development industry trends over the coming years.
UK Cell Line Development Market size, by Product, 2012-2023 (USD Million)
This industry is analyzed based on products, source, cell line, geography, and applications. The cell line development market by product is segmented into three main types namely, reagents & media, equipment, and accessories & consumables. Reagents and media market share pegged at USD 1.5 billion in 2015 will continue to be the major product in the coming six years. Reagents & media are used in procedures including drug discovery, toxicity testing, regenerative medicines, and tissue engineering. Increasing usage of reagents & media in these measures will strengthen the product demand. Accessories and consumables market is likely to observe the highest annual growth rate of 16.3% from 2016-2023. The increasing usage rate of disposables in monoclonal antibodies and vaccines will in turn boost the cell line development industry. Equipment product segment is estimated to surpass USD 3 billion by 2023. This product segment accounted for 41.4% market share in 2015, and is expected to lose ground to the accessories and consumables market over the coming years.
Get a Sample Copy of this Report:@ https://www.gminsights.com/request-sample/detail/429
Mammalian and non-mammalian are the two types of sources in the cell line development industry. Within this, the non-mammalian is further classified into insects and amphibians. Mammalian cell line development dominated the market share in 2015 and is expected to exhibit similar trends, driven by the improved engineering and expression systems. Furthermore, the non-mammalian source market accounted for 25% of the industry share in 2015.
Based on cell line; recombinant, primary cell line, hybridomas, and continuous cell line are the four types in the cell line development industry. Among the four, recombinant cell line development market attained the highest industry share in 2015. Over the coming years, this market is probable to lose industry share to the hybridomas and primary cell line segments. Hybridoma cells accounted for the second highest market share in 2015. These cells are grown at larger density in culture flasks and roller bottles. Growing hybridoma cells culture, which can produce high density cultures over 15 to 25 times will in turn fuel the global cell line development industry growth.
Considering the global trends, North America led the global cell line development industry, owing to enhanced healthcare infrastructure, rinsing awareness regarding cell therapy, and increasing demand for biologics in the U.S. The U.S. cell line development market is projected to account for 85% market share over the period of 2016-2023.
Asia Pacific cell line development market is witnessing a significant growth due to existence of developing healthcare infrastructure, favorable government policies, rapid economic development. Significant investments by the global companies, mainly in India and China, will flourish the regional growth.
Latin America cell line development market is foreseen to register a CAGR of 13.3% over the period of 2016-2023. Brazil is another emerging market witnessing healthy growth in the cell line development industry.
Tissue engineering, research, drug discovery, bioproduction, and toxicity testing are the key application segments in the cell line development industry. Bioproduction application occupied the highest market value of USD 1306 million, shadowed by toxicity testing application market worth USD 598.3 million in 2015. The bioproduction is the leading application which is estimated to surpass USD 3 billion by 2023. The presence of advanced processes, introduction of biosimilars, and increase in R&D activities are the attributing factors in augmenting the overall segment growth.
The industry will witness intense competition and strategic initiatives to sustain the market position. The market is dominated by a limited number of players with better financial muscle thus providing threat to the new entrants in the industry. Notable companies operating in cell line development industry are Selexis American Type Culture Collection (ATCC), Thermo Fisher Scientific, GE Healthcare, Lonza Group, WuXi AppTec, European Collection of Cell Cultures (ECACC), Sigma-Aldrich Corporation, Sartorious, and Corning.
Author Name : Ojaswita Kutepatil
Molecular Diagnostics Market Outlook: Surging Point of Care (PoC) diagnostics demand to stimulate the industry growth
Germany Molecular diagnostics market size, by technology, 2012-2023 (USD Million)
DNA/RNA Purification, PCR (Polymerase chain reaction), and Real-Time PCR are some of the key molecular diagnostics technologies. PCR, which accounted for 46% of molecular diagnostics industry share in 2015, is expected to contribute significantly towards the overall revenue over the coming timeframe. Real time PCR is also expected to make substantial contributions towards molecular diagnostics market size, driven by breakthroughs in clinical microbiology, molecular biology, and instrumentation.
Get a Sample Copy of this Report:@ https://www.gminsights.com/request-sample/detail/434
Contagious diseases such as tuberculosis, hepatitis C, flu, RSV (Respiratory syncytial virus), meningitis, hepatitis B, HPV (human papillomavirus), Dengue, and STD (Sexually Transmitted Disease) are projected to contribute significantly towards molecular diagnostics market revenue over the next few years. STD, which covered a major portion of the overall revenue in 2015, is expected to offer lucrative growth opportunities for the industry over the next few years. High occurrence of sexually transmitted diseases along with the use of advanced diagnostic procedures will drive the growth. HPV is anticipated to nurture molecular diagnostics industry growth over 2016-2023. Rise in HPV infections across the globe is expected to drive the growth.
Below are the regional trends influencing molecular diagnostics market over 2016-2023
- APAC molecular diagnostics industry size is expected to grow considerably over the coming timeframe. Rise in incidence of contagious diseases as well HAIs (hospital acquired infections), high patient population base, fast economic development, and preventive healthcare legislations will be the key driving factors. China, Malaysia, and India are predicted to be the major regional revenue contributors.
- Introduction of new technologies, enhanced healthcare facilities, increase in patient awareness level regarding early diagnosis of the ailment, and heavy funding for R&D activities associated with drug discovery will boost North America molecular diagnostics market revenue over the coming six years. U.S. is expected to be the key regional growth driver.
- Large acceptance of modern technologies along with high investments across the healthcare sector to improve the care services is expected to accelerate Europe molecular diagnostics industry growth. Germany is projected to contribute considerably towards the regional share.
- Africa molecular diagnostics industry revenue, estimated at over USD 130 million in 2015, is expected to grow at a rate of 9.5% over 2016-2023. High acceptance of novel technologies such as PoC diagnostic kits plus rise in occurrence of contagious diseases is forecast to drive the regional growth.
Market players will try to expand their product portfolio through strategic collaborations and joint ventures. Key industry participants include Johnson & Johnson, bioMerieux, Becton Dickinson, Abbott Laboratories, Danaher Corporation, Cepheid, Bio-Rad Laboratories, Bayer Healthcare, F. Hoffmann-La Roche AG, Siemens Healthcare, Dako, and Novartis.
Author Name : Dhananjay Punekar
Prolonged stays in the hospitals may result into rising prevalence of nosocomial infections caused by bacteria, virus, and fungal pathogens. Rising consciousness towards these infections will favor the home infusion therapy industry in the coming six years. The home infusion therapy industry size is estimated to surpass USD 26 billion by 2023. Furthermore, new advancements in the infusion pumps will generate attractive growth avenues in the home infusion therapy market. For instance, the introduction of smart pumps and Wi-Fi enabled pumps have escalated the demand for the home infusion therapy services.
UK Home Infusion Therapy Market size, by application, 2012-2023 (USD Million)
Some of the prominent application areas of the home infusion therapy industry include Anti-infective, Parenteral Nutrition, Specialty Pharmaceuticals, Hydration Therapy, Chemotherapy, and Enteral Nutrition. The anti-infective application in the home infusion therapy market is projected to exceed USD 7 billion by 2023, owing to growing geriatric population and rising occurrence of transferable & infectious diseases. Enteral nutrition is another lucrative application in the home infusion therapy market, which is anticipated to grow at an annual rate of 9% over the period of 2016-2023. The industry growth is subject to the growing incidence of chronic disease including diabetes, cancer, and gastrointestinal infections. Moreover, growth in disposable income and increasing demand for home-based therapy will fuel the industry outlook.
Get a Sample Copy of this Report:@ https://www.gminsights.com/request-sample/detail/435
Considering the product segmentation of the home infusion therapy market, infusion pumps accounted for more than 50% of the overall industry share. Need for high precision and new technological advents with feature including alarms, barcode technology, etc. will majorly drive the infusion pumps market. Apart from this, needleless connectors market is another profitable product segment, which is projected to register a CAGR of 9.5% over the period of 2016-2023. Rising concerns over needle stick injuries and increasing demand for safety will spur the industry growth. Needleless connectors are the fastest growing product segment anticipated to surpass USD 7.9 billion by 2023.
Geographically, U.S. home infusion therapy market led the industry by accounting for 90% of the regional revenue in 2015. Favorable government policies and access to care facilities in healthcare will augment the industry growth. The U.S. home infusion therapy industry is anticipated to surpass USD 10 billion by 2023. Europe home infusion therapy market will continue to be the second largest regional industry, driven by the promising reimbursement schemes and adoption of home care services.
Mergers and acquisitions, new product development and strategic alliances with healthcare institutes are the major growth strategies implemented by the market players. Notable industry participants include Baxter, CareFusion Corporation, Smiths Medical, Terumo Corporation, B. Braun Melsungen, ICU Medical, and Fresenius Kabi.
Author Name : Ojaswita Kutepatil
Breast Pump Market outlook: Electric breast pumps to exhibit a heavy growth potential over 2016-2024
The global breast pump market is expected to achieve high growth as companies are actively investing in various strategies to create discrete valuable schemes and proposals for varied consumer segments offering innovative and cost-effective treatment for breastfeeding. Today, most of the women have balanced work & life priorities and this will produce a favorable impact on the breast pump industry dynamics. Moreover, exponentially increasing birth rates coupled with rising awareness regarding breast feeding will further propel the breast pump demand, thereby driving the industry trends. According to Global Market Insights, Inc., “Breast pump market size is anticipated to grow at a CAGR of 7.7% over the period of 2016-2024.”
U.S. Breast Pumps Market Size, by Technology, 2012- 2024 (USD Mn)
Rapid economic development along with the rising working female population will generate lucrative avenues for the breast pump business over the coming years. The global breast pump industry is analyzed with different perspectives comprising of product type, technology used, major application base, and geography.
Get a Sample Copy of this Report:@ https://www.gminsights.com/request-sample/detail/729
Based on mode of operation and technology the breast pump industry is segmented into four main types namely manual, battery powered, and electric. The battery powered breast pump market is estimated to surpass USD 816 million by 2024. Moreover, electric breast pump market is another lucrative industry to attain a CAGR of 10.6% over the period of 2016-2024. Electric pumps have an advantage of higher efficiency and user friendly technology which generates a greater demand for this technology. Cost efficiency is another major factor behind the growth in this segment.
Breast pumps witness a wide set of applications in the personal use and hospital grade sector. In this bifurcation, the hospital grade electric pumps are poised to witness favorable industry expansion, owing to its features such as strength, durability, and multiple user ability. The hospital grade pumps are set to witness heavy gains with target market size slated to surpass USD 520 million by 2024.
Geographically, North America breast pump market is projected to exhibit healthy growth over the coming seven years. U.S. breast pump industry, worth USD 405 million in 2015, is projected to grow at an annual rate of 4.9% over the period of 2016-2024. Highly available healthcare amenities along with growing healthcare expenditure is likely to be major factors booming the regional landscape over the coming years.
Asia pacific breast pump industry is anticipated to witness escalating gains over the coming years. The growth is attributed to rising women employment rate, increasing awareness levels, increasing birth rates, and increasing disposable income. Japan, China, and India are expected to be the major regional revenue pockets.
Europe breast pump market, is foreseen to grow significantly, driven by increasing cognizance towards breastfeeding. UK and Germany are expected to drive the regional growth.
LATAM breast pump market is projected to cross USD 14 million by 2024, driven by better healthcare services and introduction of new breast pumps. It is expected that Brazil will contribute considerably towards the regional share.
Breast pump industry is highly concentrated and is dominated by few notable players including Philips, Hygeia Medical Group, Whittlestone, Ameda Breastfeeding Solutions, Medela, Bailey Medical, and Energizer Personal Care.
Author Name : Ojaswita Kutepatil
Gene editing market is slated to register a massive double-digit growth rate over the coming seven years. The rising number of biotechnology and pharmaceutical firms will provide heavy revenue generating opportunities for the gene editing industry players over the coming years. Moreover, increasing prevalence of cancer and genetic disorders will further enhance the scope of the gene editing market. According to Global Market Insights, Inc. “Global gene editing market size worth USD 2.17 billion in 2015, is estimated to witness a CAGR of 14% over the period of 2016-2024.”
The rapid technological advancements in healthcare industry will also build a profitable roadmap for the gene-editing industry. Precision medicine market, which is estimated to surpass a revenue of USD 85 billion by 2023, will also promote the gene-industry market trends. The government support and increasing investments in R&D to enhance the technological outlook will also boost the gene editing industry share notably over the coming timeframe. The pharmaceutical industry is also actively collaborating with the gene editing firms to implement the technology use in clinical development. In addition to this, the industry will gain wide acceptance on account of its benefits in the wellbeing of humans, animals, and plant ecosystems.
U.S. Gene Editing Market Size, by Application, 2013- 2024 (USD Million)
Gene editing industry finds a varied set of applications across areas such as oncology, muscular disorders, infectious disease, and hematology. Hematology led the application landscape with a revenue of USD 807 million in 2015. Rising prevalence of infectious diseases such as HIV will promote the gene editing industry size in infectious disease applications, with a revenue estimation of USD 2.5 billion by 2024. Moreover, oncology applications will also exhibit a decent growth rate over the coming seven years, with an annual CAGR of 16% over 2016-2024. The increasing number and types of cancer will primarily contribute towards the application growth.
Get a Sample Copy of this Report:@ https://www.gminsights.com/request-sample/detail/810
CRISPR/Cas9 is the most prominent technology implemented in the gene editing applications and has been the most buzzed topic among the researchers worldwide. The ability of CRISPR/Cas9 technology to enable multiple edits at once has made it a breakthrough in the gene editing technology landscape. Moreover, its simplicity, specificity, and speed will further promote the technology demand over the coming years. CRISPR technology based gene editing market is estimated to exceed a revenue of USD 3 billion by 2024. Other notable technologies deployed in the gene editing industry include TALENS, Mega nucleases, and Zinc Finger Nucleases (ZFNs).
The major end-users participating in the gene editing market include CROs (Contract Research Organizations), Biotech & Pharma companies, and Research Institutes. Biotech and Pharma dominated the end user landscape accounting for 58% of the overall market share in 2015. The growth can be attributed to increasing applications of gene editing in therapeutics and drug discovery. Moreover, enhancements in the field of genetic engineering will further expand the scope of gene editing market in biotech and pharma sector. CROs will also emerge as a prominent revenue generating sector due to increased outsourcing by the pharmaceutical companies for complex drug discovery.
Considering the global trends, US gene editing industry led the global landscape, with a revenue of USD 518 million in 2015. The trend is likely to continue with the rapid expansion of biotech and pharma industry coupled with the rising prevalence of diseases such as Alzheimer, cancer, and other infectious ailments. UK gene editing market is anticipated to surpass USD 744 million by 2024, driven by the growing geriatric population base and frequent occurrence of chronic ailments across Europe. Asia Pacific will also exhibit substantial growth over the coming years. Improving healthcare infrastructure, technological developments in the medical space, rising geriatric population base, and favorable government norms will stimulate the APAC market growth.
Lack of awareness about gene-editing may prove to be a roadblock for the market growth. However, the government support towards spreading awareness will undoubtedly improve the future business scenario. The emerging economies will gain a major traction of the industry players to expand the regional base. Key market participants include Agilent Technologies, AstraZeneca, Allele Biotech, Cellectis, Bio Rad, Editas Medicine, CRISPR Therapeutics, Lonza, GE Healthcare Dharmacon, Recombinetics, Inc., Qiagen, Thermo Fisher Scientific, and Sigma-Aldrich.
Author Name : Shikha Sinha
Global enteral feeding devices market is poised to witness a remarkable surge, owing to the growing geriatric population base, increasing pre-term births, and rising incidences of chronic diseases. In addition to this, rising awareness in the patients regarding advance diagnosis tests for early stage diseases and cost effective treatments indicates lucrative growth opportunities for the enteral feeding devices industry. According to Global Market Insights, Inc. “Enteral Feeding Devices Market size is estimated to witness a CAGR of 6.1% over the period of 2016-2023.” Moreover, innovations and technological advancements in order to meet different patients’ demand such as portability, accuracy, and user-friendly features will fuel the growth of the enteral feeding devices market.
U.S. Enteral Feeding Devices Market size, by Product, 2012- 2024 (USD Mn)
Enteral feeding devices have transformed the healthcare and the medical nutrition industry, where these devices are used for delivering nutritionally complete food containing fat, protein, carbohydrate, minerals, and vitamins directly into the stomach or intestine of the patients. The enteral feeding devices are majorly used by the patients who are unable to obtain their nutritional needs through the oral route. The beneficial role played by the feeding devices, tubes, and pumps for the suffering patients will augment the enteral feeding devices industry.
Get a Sample Copy of this Report:@https://www.gminsights.com/request-sample/detail/745
Based on the product type, the enteral feeding devices market is segmented into the enteral feeding pump, gastrostomy devices, gastrostomy tube, nasogastric tube, giving set, percutaneous endoscopic gastrostomy devices, and low profile gastrostomy device. The rising prevalence of preterm births, growing geriatric population and increasing use of device in home care settings for patients are the key factors driving the enteral feeding devices product landscape.
Enteral feeding pumps market revenue contributing to the highest industry share is projected to beat USD 3.5 billion by 2024. Enteral feeding pump is estimated to be the leading segment registering a CAGR of 6.1% over the period of 2016-2024. Moreover, nasogastric tubes and percutaneous endoscopic gastrostomy devices market will also witness a significant surge in the coming seven years. Furthermore, technological advancements in the product have led to rise in sales of enteral pumps such as companion enteral nutrition pumps, patrol enteral pump, and flexiflo quantum enteral pump.
Geographically, Europe enteral feeding devices market accounting for largest industry share, is set to cross USD 1 billion by 2024, owing to rising patient awareness levels, high healthcare expenditure, increasing geriatric population, and highly developed healthcare facilities. Moreover, implementation of favorable regulations and growing R&D for advancement in product portfolio will augment the enteral feeding devices industry growth.
Asia Pacific enteral feeding devices industry, with growth imminent from China and India, is on the verge of becoming most profitable market with an annual growth rate of 6.8% over the period of 2016-2024. Presence of high geriatric population in Japan is also likely to elevate the business opportunities for the enteral feeding devices industry.
Global enteral feeding devices industry is consolidated with key industry players sharing 70% of the overall business space. The notable industry participants include Abbott Nutrition, Nestle, Fresenius Kabi, Danone, Conmed Corporation, Amsino International Inc., Cook Medical, Kimberly Clark Corporation, etc.
Author Name : Ojaswita Kutepatil